Ekizoglu, E. 2018. Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study). TURKISH JOURNAL OF NEUROLOGY , vol.24, no.2 , 199-200.

Ekizoglu, E., (2018). Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study). TURKISH JOURNAL OF NEUROLOGY , vol.24, no.2, 199-200.

Ekizoglu, Esme. "Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)," TURKISH JOURNAL OF NEUROLOGY , vol.24, no.2, 199-200, 2018

Ekizoglu, Esme E. . "Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)." TURKISH JOURNAL OF NEUROLOGY , vol.24, no.2, pp.199-200, 2018

Ekizoglu, E. (2018) . "Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)." TURKISH JOURNAL OF NEUROLOGY , vol.24, no.2, pp.199-200.

@article{article, author={Esme EKİZOĞLU TURGUT}, title={Idarucizumab for Dabigatran Reversal-full Cohort Analysis (RE-VERSE AD Study)}, journal={TURKISH JOURNAL OF NEUROLOGY}, year=2018, pages={199-200} }